{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:43:24Z","timestamp":1791895404552,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"DOI":"10.7759\/cureus.83345","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T09:13:55Z","timestamp":1746177235000},"source":"Crossref","is-referenced-by-count":4,"title":["Guidance for the Management of Rectal Cancer: An Umbrella Review of Existing Guidelines Regarding Surgical Anatomy, Adjuvant Therapy, Follow-Up and Surveillance, Specific Considerations, Documentation, and Palliative Care"],"prefix":"10.7759","author":[{"given":"Ionut","family":"Negoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sopen.2024.01.009","article-title":"Contemporary management of rectal cancer","volume":"18","author":"Troester AM","year":"2024","unstructured":"Troester AM, Gaertner WB. Contemporary management of rectal cancer. Surg Open Sci. 2024, 18:17-22. 10.1016\/j.sopen.2024.01.009","journal-title":"Surg Open Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v16.i2.100807","article-title":"Current and future perspectives in the management and treatment of colorectal cancer","volume":"16","author":"Romero-Zoghbi SE","year":"2025","unstructured":"Romero-Zoghbi SE, Krumina E, L\u00f3pez-Campos F, Cou\u00f1ago F. Current and future perspectives in the management and treatment of colorectal cancer. World J Clin Oncol. 2025, 16:100807. 10.5306\/wjco.v16.i2.100807","journal-title":"World J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.62463\/surgery.134","article-title":"Generative artificial intelligence transparency in scientific writing: the GAIT 2024 guidance","volume":"2","author":"Linder C","year":"2025","unstructured":"Linder C, Nepogodiev D. Generative artificial intelligence transparency in scientific writing: the GAIT 2024 guidance. Impact Surgery. 2025, 2:6-11. 10.62463\/surgery.134","journal-title":"Impact Surgery"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003251","article-title":"Definition of the rectum: an international, expert-based Delphi consensus","volume":"270","author":"D\u02bcSouza N","year":"2019","unstructured":"D\u02bcSouza N, de Neree Tot Babberich MP, d'Hoore A, et al.. Definition of the rectum: an international, expert-based Delphi consensus. Ann Surg. 2019, 270:955-9. 10.1097\/SLA.0000000000003251","journal-title":"Ann Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/codi.16005","article-title":"Evaluation of the implementation of the sigmoid take-off landmark in the Netherlands","volume":"24","author":"Hazen SJ","year":"2022","unstructured":"Hazen SJ, Sluckin TC, Horsthuis K, Lambregts DM, Beets-Tan RG, Tanis PJ, Kusters M. Evaluation of the implementation of the sigmoid take-off landmark in the Netherlands. Colorectal Dis. 2022, 24:292-307. 10.1111\/codi.16005","journal-title":"Colorectal Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.01.008","article-title":"The sigmoid take-off: an anatomical imaging definition of the rectum validated on specimen analysis","volume":"46","author":"D'Souza N","year":"2020","unstructured":"D'Souza N, Lord A, Shaw A, et al.. The sigmoid take-off: an anatomical imaging definition of the rectum validated on specimen analysis. Eur J Surg Oncol. 2020, 46:1668-72. 10.1016\/j.ejso.2020.01.008","journal-title":"Eur J Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/codi.13705","article-title":"Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - multidisciplinary management","volume":"19","author":"Gollins S","year":"2017","unstructured":"Gollins S, Moran B, Adams R, et al.. Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - multidisciplinary management. Colorectal Dis. 2017, 19:37-66. 10.1111\/codi.13705","journal-title":"Colorectal Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/codi.12501","article-title":"The English national low rectal cancer development programme: key messages and future perspectives","volume":"16","author":"Moran BJ","year":"2014","unstructured":"Moran BJ, Holm T, Brannagan G, et al.. The English national low rectal cancer development programme: key messages and future perspectives. Colorectal Dis. 2014, 16:173-8. 10.1111\/codi.12501","journal-title":"Colorectal Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrae029","article-title":"Total mesorectal excision in MRI-defined low rectal cancer: multicentre study comparing oncological outcomes of robotic, laparoscopic and transanal total mesorectal excision in high-volume centres","volume":"8","author":"Rutgers ML","year":"2024","unstructured":"Rutgers ML, Burghgraef TA, Hol JC, et al.. Total mesorectal excision in MRI-defined low rectal cancer: multicentre study comparing oncological outcomes of robotic, laparoscopic and transanal total mesorectal excision in high-volume centres. BJS Open. 2024, 8:zrae029. 10.1093\/bjsopen\/zrae029","journal-title":"BJS Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-018-6530-4","article-title":"Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes","volume":"33","author":"Roodbeen SX","year":"2019","unstructured":"Roodbeen SX, Penna M, Mackenzie H, et al.. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes. Surg Endosc. 2019, 33:2459-67. 10.1007\/s00464-018-6530-4","journal-title":"Surg Endosc"},{"key":"ref12","article-title":"CSCO guidelines for colorectal cancer version 2023: updates and insights","volume":"35","author":"Mi M","year":"2023","unstructured":"Mi M, Weng S, Xu Z, Hu H, Wang Y, Yuan Y. CSCO guidelines for colorectal cancer version 2023: updates and insights. Chin J Cancer Res. 2023, 35:233-8.","journal-title":"Chin J Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-024-02930-6","article-title":"The use of indocyanine green for lateral lymph node dissection in rectal cancer-preliminary data from an emerging procedure: a systematic review of the literature","volume":"28","author":"Kehagias D","year":"2024","unstructured":"Kehagias D, Lampropoulos C, Bellou A, Kehagias I. The use of indocyanine green for lateral lymph node dissection in rectal cancer-preliminary data from an emerging procedure: a systematic review of the literature. Tech Coloproctol. 2024, 28:53. 10.1007\/s10151-024-02930-6","journal-title":"Tech Coloproctol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/710569","article-title":"Systematic review: adjuvant chemotherapy for locally advanced rectal cancer with respect to stage of disease","volume":"2015","author":"Hajibandeh S","year":"2015","unstructured":"Hajibandeh S, Hajibandeh S. Systematic review: adjuvant chemotherapy for locally advanced rectal cancer with respect to stage of disease. Int Sch Res Notices. 2015, 2015:710569. 10.1155\/2015\/710569","journal-title":"Int Sch Res Notices"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2019.10.021","article-title":"Improved survival with adjuvant chemotherapy in locally advanced rectal cancer patients treated with preoperative chemoradiation regardless of pathologic response","volume":"32","author":"Gahagan JV","year":"2020","unstructured":"Gahagan JV, Whealon MD, Phelan MJ, et al.. Improved survival with adjuvant chemotherapy in locally advanced rectal cancer patients treated with preoperative chemoradiation regardless of pathologic response. Surg Oncol. 2020, 32:35-40. 10.1016\/j.suronc.2019.10.021","journal-title":"Surg Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds278","article-title":"Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study","volume":"24","author":"Tiselius C","year":"2013","unstructured":"Tiselius C, Gunnarsson U, Smedh K, Glimelius B, P\u00e5hlman L. Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study. Ann Oncol. 2013, 24:160-5. 10.1093\/annonc\/mds278","journal-title":"Ann Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000185","article-title":"The efficacy of adjuvant chemotherapy in patients with stage II\/III resected rectal cancer treated with neoadjuvant chemoradiation therapy","volume":"40","author":"Ahn DH","year":"2017","unstructured":"Ahn DH, Wu C, Wei L, et al.. The efficacy of adjuvant chemotherapy in patients with stage II\/III resected rectal cancer treated with neoadjuvant chemoradiation therapy. Am J Clin Oncol. 2017, 40:531-4. 10.1097\/COC.0000000000000185","journal-title":"Am J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2021.02.006","article-title":"Patient risk subgroups predict benefit of adjuvant chemotherapy in stage II rectal cancer patients following neoadjuvant chemoradiation and total mesorectal excision","volume":"20","author":"Naffouje S","year":"2021","unstructured":"Naffouje S, Sabesan A, Powers BD, et al.. Patient risk subgroups predict benefit of adjuvant chemotherapy in stage II rectal cancer patients following neoadjuvant chemoradiation and total mesorectal excision. Clin Colorectal Cancer. 2021, 20:e155-64. 10.1016\/j.clcc.2021.02.006","journal-title":"Clin Colorectal Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103627","article-title":"Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials","volume":"172","author":"Tamburini E","year":"2022","unstructured":"Tamburini E, Tassinari D, Ramundo M, et al.. Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials. Crit Rev Oncol Hematol. 2022, 172:103627. 10.1016\/j.critrevonc.2022.103627","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v12.i4.503","article-title":"Adjuvant chemotherapy in curatively resected rectal cancer: how valid are the data?","volume":"12","author":"Manzini G","year":"2020","unstructured":"Manzini G, Hapke F, Hines IN, Henne-Bruns D, Kremer M. Adjuvant chemotherapy in curatively resected rectal cancer: how valid are the data?. World J Gastrointest Oncol. 2020, 12:503-13. 10.4251\/wjgo.v12.i4.503","journal-title":"World J Gastrointest Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00016","article-title":"Oxaliplatin-based adjuvant chemotherapy for rectal cancer after preoperative chemoradiotherapy (ADORE): long-term results of a randomized controlled trial","volume":"37","author":"Hong YS","year":"2019","unstructured":"Hong YS, Kim SY, Lee JS, et al.. Oxaliplatin-based adjuvant chemotherapy for rectal cancer after preoperative chemoradiotherapy (ADORE): long-term results of a randomized controlled trial. J Clin Oncol. 2019, 37:3111-23. 10.1200\/JCO.19.00016","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000907","article-title":"Adjuvant chemotherapy after preoperative chemoradiation improves survival in patients with locally advanced rectal cancer","volume":"60","author":"Sun Z","year":"2017","unstructured":"Sun Z, Gilmore B, Adam MA, Kim J, Hsu SD, Migaly J, Mantyh CR. Adjuvant chemotherapy after preoperative chemoradiation improves survival in patients with locally advanced rectal cancer. Dis Colon Rectum. 2017, 60:1050-6. 10.1097\/DCR.0000000000000907","journal-title":"Dis Colon Rectum"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22460","article-title":"Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II-IV rectal cancer","volume":"8","author":"Wu Y","year":"2017","unstructured":"Wu Y, Liu H, Du XL, et al.. Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II-IV rectal cancer. Oncotarget. 2017, 8:106913-25. 10.18632\/oncotarget.22460","journal-title":"Oncotarget"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu560","article-title":"Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial","volume":"26","author":"Breugom AJ","year":"2015","unstructured":"Breugom AJ, van Gijn W, Muller EW, et al.. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. Ann Oncol. 2015, 26:696-701. 10.1093\/annonc\/mdu560","journal-title":"Ann Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer R","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S, et al.. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012, 30:1926-33. 10.1200\/JCO.2011.40.1836","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004078.pub2","article-title":"Postoperative adjuvant chemotherapy in rectal cancer operated for cure","volume":"2012","author":"Petersen SH","year":"2012","unstructured":"Petersen SH, Harling H, Kirkeby LT, Wille-J\u00f8rgensen P, Mocellin S. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev. 2012, 2012:CD004078. 10.1002\/14651858.CD004078.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000001762","article-title":"The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of rectal cancer","volume":"63","author":"You YN","year":"2020","unstructured":"You YN, Hardiman KM, Bafford A, et al.. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of rectal cancer. Dis Colon Rectum. 2020, 63:1191-222. 10.1097\/DCR.0000000000001762","journal-title":"Dis Colon Rectum"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones R","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, Arnold D. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017, 28:iv22-40. 10.1093\/annonc\/mdx224","journal-title":"Ann Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0041","article-title":"NCCN Guidelines\u00ae insights: rectal cancer, version 3.2024","volume":"22","author":"Benson AB","year":"2024","unstructured":"Benson AB, Venook AP, Adam M, et al.. NCCN Guidelines\u00ae insights: rectal cancer, version 3.2024. J Natl Compr Canc Netw. 2024, 22:366-75. 10.6004\/jnccn.2024.0041","journal-title":"J Natl Compr Canc Netw"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/codi.13706","article-title":"Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - follow up, lifestyle and survivorship","volume":"19","author":"Leong K","year":"2017","unstructured":"Leong K, Hartley J, Karandikar S. Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - follow up, lifestyle and survivorship. Colorectal Dis. 2017, 19:67-70. 10.1111\/codi.13706","journal-title":"Colorectal Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-019-01485-z","article-title":"Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer","volume":"25","author":"Hashiguchi Y","year":"2020","unstructured":"Hashiguchi Y, Muro K, Saito Y, et al.. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020, 25:1-42. 10.1007\/s10147-019-01485-z","journal-title":"Int J Clin Oncol"},{"key":"ref32","unstructured":"Colorectal cancer. (2020). Accessed. 2025: https:\/\/www.nice.org.uk\/guidance\/ng151."},{"key":"ref33","article-title":"National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)","volume":"35","author":"Association NH","year":"2023","unstructured":"Association NH. National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version). Chin J Cancer Res. 2023, 35:197-232.","journal-title":"Chin J Cancer Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2016.06.023","article-title":"Efficacy of palliative radiation therapy for symptomatic rectal cancer","volume":"121","author":"Chia D","year":"2016","unstructured":"Chia D, Lu J, Zheng H, et al.. Efficacy of palliative radiation therapy for symptomatic rectal cancer. Radiother Oncol. 2016, 121:258-61. 10.1016\/j.radonc.2016.06.023","journal-title":"Radiother Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.03.010","article-title":"Palliative short-course radiation therapy in\u00a0rectal cancer: a phase 2 study","volume":"95","author":"Picardi V","year":"2016","unstructured":"Picardi V, Deodato F, Guido A, et al.. Palliative short-course radiation therapy in\u00a0rectal cancer: a phase 2 study. Int J Radiat Oncol Biol Phys. 2016, 95:1184-90. 10.1016\/j.ijrobp.2016.03.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref36","unstructured":"Standardized operative report. (2024). Accessed. December 8, 2024: https:\/\/www.ascrsu.com\/ascrs\/view\/Fundamentals-of-Rectal-Cancer-Surgery\/2831021\/all\/Standardized.."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/codi.13708","article-title":"Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - pathology standards and datasets","volume":"19","author":"Langman G","year":"2017","unstructured":"Langman G, Loughrey M, Shepherd N, Quirke P. Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - pathology standards and datasets. Colorectal Dis. 2017, 19:74-81. 10.1111\/codi.13708","journal-title":"Colorectal Dis"},{"key":"ref38","article-title":"UK Professor Philip Quirke, Leeds Teaching Hospitals NHS Trust & Leeds University, UK Professor Neil A Shepherd, Gloucestershire Cellular Pathology Laboratory, Cheltenham, UK: Standards and datasets for reporting cancers: Dataset for histopathological reporting of colorectal cancer","author":"Loughrey MB","year":"2018","unstructured":"Loughrey MB, Quirke P, Shepherd NA. Standards and Datasets for Reporting Cancers: Dataset for Histopathological Reporting of Colorectal Cancer. Royal College of Pathologists, London; 2018. https:\/\/www.rcpath.org\/static\/c8b61ba0-ae3f-43f1-85ffd3ab9f17cfe6\/G049-Dataset-for-histopathological-reporting-of-col...."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/codi.13707","article-title":"Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - audit and outcome reporting","volume":"19","author":"Faiz O","year":"2017","unstructured":"Faiz O. Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - audit and outcome reporting. Colorectal Dis. 2017, 19:71-3. 10.1111\/codi.13707","journal-title":"Colorectal Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000002341","article-title":"Differential effects of race, socioeconomic status, and insurance on disease-specific survival in rectal cancer","volume":"66","author":"Del Rosario M","year":"2023","unstructured":"Del Rosario M, Chang J, Ziogas A, Clair K, Bristow RE, Tanjasiri SP, Zell JA. Differential effects of race, socioeconomic status, and insurance on disease-specific survival in rectal cancer. Dis Colon Rectum. 2023, 66:1263-72. 10.1097\/DCR.0000000000002341","journal-title":"Dis Colon Rectum"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2018.1658","article-title":"Impact of multidisciplinary tumor boards on patients with rectal cancer","volume":"9","author":"Ioannidis A","year":"2018","unstructured":"Ioannidis A, Konstantinidis M, Apostolakis S, Koutserimpas C, Machairas N, Konstantinidis KM. Impact of multidisciplinary tumor boards on patients with rectal cancer. Mol Clin Oncol. 2018, 9:135-7. 10.3892\/mco.2018.1658","journal-title":"Mol Clin Oncol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1713749","article-title":"Improving rectal cancer outcomes with the National Accreditation Program for Rectal Cancer","volume":"33","author":"Wexner SD","year":"2020","unstructured":"Wexner SD, White CM. Improving rectal cancer outcomes with the National Accreditation Program for Rectal Cancer. Clin Colon Rectal Surg. 2020, 33:318-24. 10.1055\/s-0040-1713749","journal-title":"Clin Colon Rectal Surg"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckv237","article-title":"Improving clinical outcomes through centralization of rectal cancer surgery and clinical audit: a mixed-methods assessment","volume":"26","author":"Prades J","year":"2016","unstructured":"Prades J, Manchon-Walsh P, Sol\u00e0 J, Espin\u00e0s JA, Guarga A, Borras JM. Improving clinical outcomes through centralization of rectal cancer surgery and clinical audit: a mixed-methods assessment. Eur J Public Health. 2016, 26:538-42. 10.1093\/eurpub\/ckv237","journal-title":"Eur J Public Health"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512159","article-title":"Total neoadjuvant treatment for locally advanced rectal cancer patients: where do we stand?","volume":"24","author":"Dapr\u00e0 V","year":"2023","unstructured":"Dapr\u00e0 V, Airoldi M, Bartolini M, et al.. Total neoadjuvant treatment for locally advanced rectal cancer patients: where do we stand?. Int J Mol Sci. 2023, 24:12159. 10.3390\/ijms241512159","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00655","article-title":"Quality assurance, metrics, and improving standards in rectal cancer surgery in the United States","volume":"10","author":"Xu Z","year":"2020","unstructured":"Xu Z, Fleming FJ. Quality assurance, metrics, and improving standards in rectal cancer surgery in the United States. Front Oncol. 2020, 10:655. 10.3389\/fonc.2020.00655","journal-title":"Front Oncol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2015.09.021","article-title":"High volume improves outcomes: the argument for centralization of rectal cancer surgery","volume":"159","author":"Aquina CT","year":"2016","unstructured":"Aquina CT, Probst CP, Becerra AZ, et al.. High volume improves outcomes: the argument for centralization of rectal cancer surgery. Surgery. 2016, 159:736-48. 10.1016\/j.surg.2015.09.021","journal-title":"Surgery"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.4103\/wjcs.wjcs_15_21","article-title":"Does fellowship matter? A comparison of overall survival and lymph node sampling in colon cancer resections amongst colorectal fellowship trained surgeons vs. non-colorectal specialty trained surgeons","volume":"11","author":"Pahlkotter MK","year":"2022","unstructured":"Pahlkotter MK, Snyder J, Gygi J, Sause WT, Kim HT. Does fellowship matter? A comparison of overall survival and lymph node sampling in colon cancer resections amongst colorectal fellowship trained surgeons vs. non-colorectal specialty trained surgeons. World J Colorectal Surg. 2022, 11:84-8. 10.4103\/wjcs.wjcs_15_21","journal-title":"World J Colorectal Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2023.12.005","article-title":"The value of national accreditation program for rectal cancer: a survey of accredited programs and programs seeking accreditation","volume":"175","author":"Kapadia MR","year":"2024","unstructured":"Kapadia MR, Senatore PJ, Messick C, et al.. The value of national accreditation program for rectal cancer: a survey of accredited programs and programs seeking accreditation. Surgery. 2024, 175:1007-12. 10.1016\/j.surg.2023.12.005","journal-title":"Surgery"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/bjs5.50242","article-title":"Impact of a multidisciplinary training programme on outcome of upper rectal cancer by critical appraisal of the extent of mesorectal excision with postoperative MRI","volume":"4","author":"Bondeven P","year":"2020","unstructured":"Bondeven P, Laurberg S, Hagemann-Madsen RH, Pedersen BG. Impact of a multidisciplinary training programme on outcome of upper rectal cancer by critical appraisal of the extent of mesorectal excision with postoperative MRI. BJS Open. 2020, 4:274-83. 10.1002\/bjs5.50242","journal-title":"BJS Open"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(03)01248-8","article-title":"Training and quality assurance for rectal cancer: 20 years of data is enough","volume":"4","author":"Quirke P","year":"2003","unstructured":"Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol. 2003, 4:695-702. 10.1016\/s1470-2045(03)01248-8","journal-title":"Lancet Oncol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer RR","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, et al.. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021, 22:29-42. 10.1016\/S1470-2045(20)30555-6","journal-title":"Lancet Oncol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy T","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, et al.. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021, 22:702-15. 10.1016\/S1470-2045(21)00079-6","journal-title":"Lancet Oncol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial","volume":"42","author":"Verheij FS","year":"2024","unstructured":"Verheij FS, Omer DM, Williams H, et al.. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol. 2024, 42:500-6. 10.1200\/JCO.23.01208","journal-title":"J Clin Oncol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2023.11.047","article-title":"Whether the watch-and-wait strategy has application value for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy? A network meta-analysis","volume":"47","author":"Du R","year":"2024","unstructured":"Du R, Chang Y, Zhang J, et al.. Whether the watch-and-wait strategy has application value for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy? A network meta-analysis. Asian J Surg. 2024, 47:853-63. 10.1016\/j.asjsur.2023.11.047","journal-title":"Asian J Surg"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek A","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, et al.. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med. 2022, 386:2363-76. 10.1056\/NEJMoa2201445","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/357079-guidance-for-the-management-of-rectal-cancer-an-umbrella-review-of-existing-guidelines-regarding-surgical-anatomy-adjuvant-therapy-follow-up-and-surveillance-specific-considerations-documentation-and-palliative-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T09:14:03Z","timestamp":1746177243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/357079-guidance-for-the-management-of-rectal-cancer-an-umbrella-review-of-existing-guidelines-regarding-surgical-anatomy-adjuvant-therapy-follow-up-and-surveillance-specific-considerations-documentation-and-palliative-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.83345","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}